Mediclinic to open new oncology unit
Dubai, January 27, 2014
Mediclinic City Hospital is set to open an advanced oncology unit at the Dubai Healthcare City, aimed at increasing the emirate’s cancer care capacity.
Cancer is the third leading cause of death in the UAE, after cardiovascular disease and accidents, and residents travel abroad for treatment, owing to limited oncology services.
The project, which is due for completion by the third quarter of 2015, will provide the latest diagnostic technology, said a report.
The details of the expansion were released on the sidelines of the 2014 edition of Arab Health, which began today (January 27) in Dubai.
The North Wing of Mediclinic City Hospital will offer oncology services like diagnostic, medical and radiotherapy modalities.
It will house 43 outpatient consultation suites, 17 day-care rooms, 12 dialysis suites, 11 dedicated oncology beds, two theatres and a rehabilitation centre with two fully-equipped gymnasiums. It will also include an expanded reference laboratory which will service the entire UAE healthcare community.
It will also offer therapeutic modalities for all types of cancer and will support already existing units such as the Breast Care Unit, which employs a multidisciplinary approach to breast cancer.
The new oncology unit will be built in association with Mediclinic Group’s sister company in Switzerland, Hirslanden Private Hospital Group.
David Hadley, CEO, Mediclinic Middle East, said: “The North Wing extension of Mediclinic City Hospital in DHCC continues apace. Thanks to agreements now in place with our technology partners Varian Medical Systems International AG and GE Healthcare, I am very excited by the even wider levels of service that will be available to our patients once the facility opens its doors in 2015.”
Dr Tarek Fathey, director, said: “DHCC has been very supportive of our plans and has been working closely with us to ensure that operations start smoothly once the construction starts.” - TradeArabia News Service